Enable JavaScript to ensure website accessibility
Sharon Robins Joins Precipio’s Products Division As Senior Director Of Laboratory & Hospital Sales

Precipio continues to build strong team in anticipation of substantial growth in the next 12 [...]

Precipio Launches New 1-Step Technology For All HemeScreen Assays

New technology enables same day test results by eliminating extra confirmation step NEW HAVEN, CT, [...]

Toni-Ann Mills Joins Precipio’s Products Division To Lead Channel Partner Training, Learning & Development

Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, [...]

Precipio Announces Second Quarter Shareholder Update Call

Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST NEW [...]

Precipio To Distribute HemeScreen® Through Fisher Healthcare Channel

Agreement Enhances Precipio’s Product Reach to US Laboratories NEW HAVEN, CT – (Globe Newswire) – [...]

Precipio Requests That All Stockholders That Have Not Yet Voted, Proceed To Cast Their Vote

Meeting Adjourned, new meeting set for July 5th at 10am EDT NEW HAVEN, CT – [...]

Keith Meadors Joins Precipio To Lead Its Products Division

Seasoned, experienced industry executive with a track record of managing 9-figure revenue sales organizations NEW [...]

Precipio Receives CE-IVD Certification To Market Multiple HemeScreen® Panels In Europe

This Regulatory Approval Opens the Company’s Reach to the European Market NEW HAVEN, CT – [...]

Precipio Signs First IV-Cell Customer Agreement

Laboratory operating both HemeScreen® & IV-Cell® demonstrates significant cross-sell potential NEW HAVEN, CT – (Globenewswire) [...]

Precipio Customer American Oncology Network (AON) Selected To Present HemeScreen® Technology Case Study At Industry Leading Clinical Laboratory Conference

NEW HAVEN, CT – (Apr 26th, 2022) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited [...]